Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.
Saved in:
| Title: | Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results. |
|---|---|
| Authors: | van den Ende RPJ; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands. r.p.j.van_den_ende@lumc.nl., Peters FP; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands.; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Harderwijk E; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands., Rütten H; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Bouwmans L; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Berbee M; Department of Radiation Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Canters RAM; Department of Radiation Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Stoian G; Department of Radiation Oncology, Isala Clinics, Zwolle, the Netherlands., Compagner K; Department of Radiation Oncology, Isala Clinics, Zwolle, the Netherlands., Rozema T; Department of Radiation Oncology, Verbeeten Institute, Tilburg, the Netherlands., de Smet M; Department of Radiation Oncology, Verbeeten Institute, Tilburg, the Netherlands., Intven MPW; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands., Tijssen RHN; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands., Theuws J; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., van Haaren P; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., van Triest B; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Eekhout D; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Marijnen CAM; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands.; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Heide UA; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands.; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kerkhof EM; Department of Radiation Oncology, Leiden University Medical Center, P.O. Box 9600 2300, RC, Leiden, the Netherlands. |
| Source: | Radiation oncology (London, England) [Radiat Oncol] 2020 Feb 18; Vol. 15 (1), pp. 41. Date of Electronic Publication: 2020 Feb 18. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1748-717X |
|---|---|
| DOI: | 10.1186/s13014-020-01487-6 |
